Document is current
Any future updates will be listed below
-
Authors
Srikrishna, Devabhaktuni https://orcid.org/0000-0002-5927-3623
Sachsenmeier, Kris
- License Information
-
More Information
Article History
Received: 29 June 2021
Accepted: 14 July 2021
First Online: 26 July 2021
Declarations
:
: Devabhaktuni Srikrishna is a co-founder of Breakbio Corp. which is researching novel immunotherapy combinations for Microsatellite Stable Metastatic Colorectal Cancer (MSS-mCRC). Kris Sachsenmeier has held and holds positions in translational research at AstraZeneca and Takeda Oncology, respectively, and is an unpaid advisor to Breakbio Corp.
